Clinical Trials Directory

Trials / Completed

CompletedNCT05314218

The Objective of This Multicentre Study is to Collect Operative Data on the Related Clinical Functional Outcomes and Complications and of Market Approved Alcis Electrophysiology Catheters to Demonstrate Safety and Performance of These Devices in a Real-world Setting

EPICADIA - Electrophysiologic Performance Investigation for CArdiac DIAgnosis

Status
Completed
Phase
Study type
Observational
Enrollment
168 (actual)
Sponsor
Alcis · Industry
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

The objective of this multicentre study is to collect operative data on the related clinical functional outcomes and complications and of market approved Alcis electrophysiology catheters to demonstrate safety and performance of these devices in a real-world setting.

Detailed description

Outcome data collected from this study will provide the basis for Post-Market Surveillance (PMS) reporting, Clinical Study Report (CSR), Clinical Evaluation Report (CER) on Alcis devices and support peer-reviewed publications on products performance and safety.

Conditions

Interventions

TypeNameDescription
DEVICEElectrophysiology catheters and cablesThe Xtrem electrophysiology catheter was developed for diagnosis of cardiac arrhythmias. Their function is to collect by contact, electrical signals generated by the heart muscle. Xtrem are inserted via femoral vena cava or via artery and can be used in two occasions: * Exploration procedures for diagnosis alone * Diagnosis before ablation procedure An extension cable is used to connect the catheter to a stimulation/ recording device.

Timeline

Start date
2022-05-23
Primary completion
2023-05-25
Completion
2023-05-26
First posted
2022-04-06
Last updated
2023-06-13

Locations

2 sites across 1 country: France

Source: ClinicalTrials.gov record NCT05314218. Inclusion in this directory is not an endorsement.